Δημοσίευση

eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.

ΤίτλοςeLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.
Publication TypeJournal Article
Year of Publication2013
AuthorsTriantafyllou, A., Pyrpasopoulou A., Anyfanti P., Balaska E., Aslanidis S., & Douma S.
JournalAnn Rheum Dis
Volume72
Issue5
Paginatione7
Date Published2013 May
ISSN1468-2060
Λέξεις κλειδιάAntibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Arthritis, Rheumatoid, B-Cell Activating Factor, Humans, Tumor Necrosis Factor-alpha
DOI10.1136/annrheumdis-2013-203240
Alternate JournalAnn Rheum Dis
PubMed ID23396663

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.